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Towards ending the human immunodeficiency
virus epidemic in the US
State of human immunodeficiency virus screening during
physician and emergency department visits, 2009 to 2014
Bankole Olatosi, PhDa,
∗
, Khairul Alam Siddiqi, MPSa, Donaldson Fadael Conserve, PhDb
Abstract
Human immunodeficiency virus (HIV) testing is important for prevention and treatment. Ending the HIV epidemic is unattainable if
significant proportions of people living with HIV remain undiagnosed, making HIV testing critical for prevention and treatment. The
Centers for Disease Control and Prevention (CDC) recommends routine HIV testing for persons aged 13 to 64 years in all health care
settings. This study builds on prior research by estimating the extent to which HIV testing occurs during physician office and
emergency department (ED) post 2006 CDC recommendations.
We performed an unweighted and weighted cross-sectional analysis using pooled data from 2 nationally representative surveys
namely National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey from 2009 to 2014. We
assessed routine HIV testing trends and predictive factors in physician offices and ED using multi-stage statistical survey procedures
in SAS 9.4.
HIV testing rates in physician offices increased by 105% (5.6–11.5 per 1000) over the study period. A steeper increase was
observed in ED with a 191% (2.3–6.7 per 1000) increase. Odds ratio (OR) for HIV testing in physician offices were highest among
ages 20 to 29 ([OR] 7.20, 99% confidence interval [CI: 4.37–11.85]), males (OR 1.34, [CI: 0.91–0.93]), African-Americans (OR 2.97,
[CI: 2.05–4.31]), Hispanics (OR 1.80, [CI: 1.17–2.78]), and among visits occurring in the South (OR 2.06, [CI: 1.23–3.44]). In the ED,
similar trends of higher testing odds persisted for African Americans (OR 3.44, 99%CI 2.50–4.73), Hispanics (OR 2.23, 99%CI 1.65–
3.01), and Northeast (OR 2.24, 99% CI 1.10–4.54).
While progress has been made in screening, HIV testing rates remains sub-optimal for ED visits. Populations visiting the ED for
routine care may suffer missed opportunities for HIV testing, which delays their entry into HIV medical care. To end the epidemic, new
approaches for increasing targeted routine HIV testing for populations attending health care settings is recommended.
Abbreviations: AIDS = acquired immunodeficiency syndrome, CDC = Centers for Disease Control and Prevention, CI =
confidence interval, ED = emergency department, HIV = human immunodeficiency virus, HMO = health maintenance organizations,
MSA =metropolitan statistical area, NAMCS = National Ambulatory Medical Care Survey, NHAMCS = National Hospital Ambulatory
Medical Care Survey, OR = odds ratio, PLWH = people living with HIV.
Keywords: emergency department, HIV testing, physician office, predictors, screening, trends
1. Introduction
Current human immunodeficiency virus/acquired immunodefi-
ciency syndrome (HIV/AIDS) surveillance estimates show
approximately 1.1 million people are living with HIV (PLWH)
in America.[1] Despite widespread availability of HIV testing,
about 15% of PLWH remain unaware of their infection.[2]
Undiagnosed PLWHmiss benefits associated with HIV diagnosis
such as early linkage to HIV care, reduction in viral load,
professional and personal support to help improve their overall
health.[3–6] To increase the proportion of PLWH who are aware
of their HIV status, receive the aforementioned benefits, and
prevent further transmission, the Centers for Disease Control and
Prevention (CDC) recommends routine HIV testing for persons
aged 13 to 64 years using routine opt-out HIV screening in health
care settings where the prevalence of undiagnosed infection is at
least 0.1%.[7] Previous studies classify health encounters by
undiagnosed PLWH in health care settings such as the emergency
department (ED) as missed opportunities for HIV testing.[8–12]
Providers play a key role in routine HIV testing with the
relationship between physician decision-making and patient
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behavior established in literature.[13,14] Based on this relationship,
the“Eisenbergmodel for clinician’s decision-making”was selected
as the theoretical model for this study.[15] This model posits that
actual clinical decisions such asHIV testing are strongly influenced
by interactions between the patient, clinician, sociological, and
biomedical environment.[13,15–17] Prior reservations about the
viability of conducting routine HIV testing in health facilities is
reduced with the development of new and successful HIV
algorithms such as the rapid test-immunoflourescence and
ARCHITECT-Multispot-viral load algorithms.[9,18] These point-
of-care testing options make HIV testing easier.[19] However,
despite these improvedHIV testing technologies and after a decade
of CDC recommendations, studies show disproportionate HIV
testing rates remain across demographic groups, and health care
settings.[6,20,21] Previous studies did not specifically account for the
impact of provider relationship inHIV testing decision-making.To
address this problem,we applied the Einsebergmodel to this study,
to examine HIV screening trends among persons aged 13 to 64
years visiting physician’s offices or ED between 2009 and 2014. In
contrast to previous studies, facility, provider, and patient-level
characteristics associated with HIV testing and trends over the 6-
year period are included as important predictors.
2. Methods
2.1. Study design and data sources
We conducted a serial cross-sectional study design, using
physician office and ED visits data obtained from the National
Ambulatory Medical Care Survey (NAMCS) and National
Hospital Ambulatory Medical Care Survey (NHAMCS) from
2009 through 2014. Both are nationally representative annual
surveys that collect visit level data using a 4-stage probability
sampling design from physician offices and hospitals in all 50
states and the District of Columbia. Details of these surveys are
available elsewhere.[22] We included visits made by persons aged
13 to 64 years over 6 years to conform with the CDCHIV testing
guidelines. Total sample size for NAMCS from 2009 to 2014was
(unweighted n=1002,) and for NHAMCS (unweighted n=783).
We extracted data from 2009 to 2014 because distinct questions
were added to the surveys in 2009 to determine whether HIV
testing was provided during the visits. Unweighted visits are only
provided in the tables to show the number of sample cases,
because each record can represent thousands of visits.
2.2. Variables
The outcome variable for this study is a dichotomous variable
defined as “HIV testing during the visit (Yes/No).” Based on
Eisenberg model of clinicians’ decision making,[15] we selected
patient level characteristics (age, sex, race, ethnicity, source of
payment, and reason of visit) and system level characteristics
(seen by physician, primary care provider, ownership of facilities,
practice region, metropolitan statistical area, and episode of care)
as explanatory variables.
2.3. Statistical analysis
Sample weights accounting for selection probability, nonre-
sponse and ratio adjustments for each year’s total sample size
were applied to generate robust national estimates of both ED
and physician office visits. Variables with unweighted values less
than 30 were excluded to ensure reliable estimates. Adjusted
sample weights, strata, and primary sampling design units
provided by both NAMCS and NHAMCS were applied using
multi-stage survey methods. Statistical procedures used include
PROC SURVEYFREQ, SURVEYMEANS, and SURVEYLO-
GISTIC. We calculated proportions with corresponding confi-
dence intervals (CIs) for all years using the total visits as
denominator. National rates were calculated using the following
equation[23]:
HIV testing rate=estimate of HIV testing/all visits=S patwt of
visits getting HIV tested/all visits
=1/(all visits
∗
S patwt of visits getting HIV tested).
We used Student t tests and Pearson Chi-square statistics to
assess differences and associations between proportions during
bivariate analysis. We used multivariable survey logistic regres-
sion to evaluate trends inHIV testing associatedwith explanatory
variables across both physician offices and EDs separately. Odds
ratios (ORs), 99% CIs, and significance level (P< .01 was
considered as significant to account for large weighted sample
sizes) for each factor are reported. No multiple comparison
adjustments were made given the exploratory nature of this
study. All analyses were performed using SAS 9.4. The study was
approved as exempt by the University of South Carolina
Institutional Review Board (#Pro00071226).
3. Results
3.1. Trends in medical visits and HIV testing rates
Average annual number of visits to the physician’s office
decreased from 3.38 (2009) to 2.77 (2014) visits per person
representing a 18% decrease over 6 years (Table 1). National
HIV testing rates in both the ED and physician offices trended
upwards as shown in Figure 1. Unexplained dips in HIV testing
rates were observed for physician offices in 2011 and for ED visits
Table 1
Average annual number of visits to physician offices and emergency departments, 2009 to 2014.
Physician office Emergency department
Year
US population
(millions)
Unweighted
sample (n)
Weighted number
of visits (millions)
Visits
per person
Unweighted
sample (n)
Weighted number
of visits (millions)
Visits
per person
2009 307.01 32281 1037.80 3.38 34942 136.07 0.44
2010 308.75 31229 1008.80 3.27 34936 129.84 0.42
2011 311.59 30872 987.03 3.17 31084 136.30 0.44
2012 313.91 76330 928.63 2.96 29453 130.87 0.42
2013 316.13 45710 922.60 2.92 24777 130.35 0.41
2014 318.86 26272 884.70 2.77 23844 141.42 0.44
Bureau of the Census, National Ambulatory Medical Care Survey, and National Hospital Ambulatory Medical Care Survey.
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in 2012. Table 2 shows national weighted and unweighted
estimates of HIV testing rates in physician offices and EDs across
different provider, patient, and facility level characteristics.
Unweighted estimates mostly mirrored weighted estimates except
in a few instances. The largest differences in HIV testing rates
across various characteristics occurred during physician office
visits. HIV testing rates fluctuated annually but were highest in
physician offices in 2014 (11.54 per 1000 visits). HIV testing
rates in physician offices were highest among those aged 20 to 29
(23.07 per 1000), African Americans (17.77 per 1000), Hispanics
(12.68 per 1000), and Medicaid beneficiaries (13.98 per 1000).
Similarly, African Americans (10.94 per 1000) and Hispanics
(8.98 per 1000) had the highest rates of HIV testing during ED
visits. For physician office visits, HIV testing rates were higher for
new patients (11.78 per 1000) compared to established patients.
Conversely, HIV testing rates were lowest among patients visiting
primary care providers (3.88 per 1000), facilities owned by
physician groups (6.13 per 1000) or making visits in nonmetro-
politan areas (5.33 per 1000).
3.2. Predictors of HIV testing
3.2.1. Patient-level characteristics. Table 3 displays the
unweighted and weighted factors associated with HIV testing
in physician offices. Four patient level characteristics – age, race
and ethnicity, sex and reason for visit were significantly
associated with HIV testing. Individuals aged 20 to 29 years
had the highest odds for testing (OR 7.20, 99% CI 4.37–11.85)
compared to the elderly age group (50–64 years). Odds for testing
was higher for males (OR 1.34, 99% CI 0.91–0.93) compared to
females. Patients visiting for preventive care had higher odds for
testing (OR 5.29, 99% CI 3.25–8.61) compared to those with a
chronic problem. Sex-age interaction was not statistically
significant for physician office/ED visits; hence data were not
displayed in Tables 3 and 4.
By race, African Americans (OR 2.97, 99% CI 2.05–4.31)
and Hispanics (OR 1.80, 99%CI 1.17–2.78) had higher odds of
receiving an HIV test during an office visit than Whites. Self-pay
individuals (OR 0.47, 99% CI 0.24–0.94) had lower odds of
HIV testing compared with the privately insured. Patients
visiting for preventive care had higher odds for testing (OR 5.29,
95% CI 3.25–8.61) compared to those with a chronic problem.
For ED visits, only 2 patient-level variables – race and ethnicity
showed significant associations with HIV testing (Table 4).
African Americans (OR 3.44, 99%CI 2.27–5.22) and Hispanics
(OR 2.24, 99% CI 1.51–3.31) had higher odds of getting tested
compared to non-Hispanic Whites.
3.2.2. System-level characteristics. All 3 system-level charac-
teristics (usual source of care captured based on new/follow-up
visit determination; primary care provider visited and facility
ownership) were significantly associated with HIV testing during
physician office visits (Table 3). New patients (OR 1.78, 99% CI
1.23–2.58)making a physician office visit had higher odds forHIV
testing compared toestablishedpatients. Similarly, patients visiting
nonprimary care providers or facilities (OR 1.61, 99% CI 1.04–
2.50) had higher odds of HIV testing. Patients visiting medical/
academic/communityhealth center/otherhospitals (OR2.21, 99%
CI1.16–4.24) hadhigher odds ofHIV testing compared topatients
visiting physician group run facilities. By region, the odds of HIV
testing occurring during a physician office visit was highest in the
South (OR 2.06, 99% CI 1.23–3.44).
4. Discussion
This study investigated HIV testing trends across patient and
system level characteristics at the physician office and ED. In
agreement with prior studies,[6,21] overall U.S. HIV testing
increased from 2009 to 2014.
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Figure 1. HIV screening rates in physician offices and emergency departments in the US, 2009 to 2014. Plots represent national HIV testing rate per 1000
occurring in Physician Offices (National Ambulatory Medical Care Survey [NAMCS] data) and Emergency Departments (National Hospital Ambulatory Medical Care
Survey [NHAMCS] data), from 2009 to 2014. HIV testing rate was calculated using the equation below: Estimate of HIV testing/all visits=Spatwt of visits getting HIV
tested/all visits = 1/(all visits
∗
S patwt of visits getting HIV tested). HIV = human immunodeficiency virus.
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Table 2
National estimates and rates of HIV testing in physician offices and emergency departments by patient and facility level factors, NAMCS
and NHAMCS pooled data 2009 to 2014.
Physician office Emergency Department
Characteristics
Unweighted
sample (n)
Unweighted
testing rate
(per 1000 visits) P value
National est.
visits with HIV
testing (millions)
Weighted
testing rate
(per 1000 visits) P value
Unweighted
sample (n)
Unweighted
testing rate
(per 1000 visits) P value
National est.
visits with HIV
testing (millions)
Testing
rate (per
1000 visits) P value
Yr <.0001 .0048 <.0001 .2561
2009 112 5.72 3.43 5.59 103 4.36 0.21 2.28
2010 156 8.29 4.99 8.31 153 6.46 0.45 5.11
2011 153 8.29 3.18 5.61 129 6.05 0.58 6.19
2012 172 3.91 3.10 5.66 143 7.12 0.49 5.51
2013 165 5.25 4.41 8.15 113 6.73 0.63 7.18
2014 244 9.29 5.94 11.54 142 9.03 0.63 6.69
Patient-level characteristics
Age, yr <.0001 <.0001 <.0001 .1022
13–19 74 5.03 1.52 4.86 96 6.44 0.33 5.06
20–29 371 17.88 10.36 23.07 238 7.75 0.90 6.41
30–39 257 9.87 6.65 11.80 173 7.04 0.67 6.18
40–49 168 5.14 3.77 5.34 148 6.43 0.54 5.28
50–64 132 2.05 2.75 2.03 128 4.57 0.54 4.30
Sex .0887 .1914 .2476 .9955
Female 634 6.59 16.49 7.94 455 6.69 1.69 5.50
Male 368 5.90 8.57 6.54 328 6.16 1.29 5.50
Race <.0001 <.0001 <.0001 <.0001
White 657 4.92 16.68 5.91 368 4.30 1.35 3.50
African American 282 16.57 6.89 17.77 363 11.85 1.50 10.94
Other 63 7.88 1.48 8.56 52 10.18 0.13 6.73
Ethnicity <.0001 <.0001 <.0001 .0004
Hispanic/Latino 198 11.97 5.09 12.68 186 10.46 0.68 8.98
Non-Hispanic/Latino 804 5.66 19.96 6.69 597 5.77 2.31 4.94
Primary source of payment <.0001 <.0001 <.0001 .0018
Private 527 5.20 15.96 7.05 149 3.67 0.75 4.06
Medicare 32 2.80 0.62 2.66 39 3.92 0.14 3.16
Medicaid 226 12.69 5.05 13.98 294 9.13 0.99 7.19
Self-pay 66 6.20 1.00 4.65 128 5.88 0.53 5.16
Others/unknown 151 8.71 2.42 7.78 173 10.36 0.57 7.88
Major reason for visit‡ <.0001 <.0001
New problem (<3 mo) 263 5.31 6.85 6.15 N/A
∗
Chronic problem 182 2.76 3.51 2.67
Preventive care 532 19.17 1.40 21.30
Diabetes (does patient have diabetes?) <.0001 <.0001 <.0001 .669
No 957 6.68 24.04 7.90 725 6.49 2.77 5.54
Yes 45 2.94 1.02 2.96 58 6.11 0.22 5.06
Arthritis† (does patient have arthritis?) <.0001 <.0001
No 968 6.88 24.29 8.13 N/A
∗
Yes 34 1.91 0.77 1.92
Obesity (does patient have obesity?) .3433 .612
No 907 6.26 22.57 7.34 N/A
∗
Yes 95 6.93 2.49 8.01
System-level characteristics
Physician seen .0264 .1206 .8870
No 18
∗
3.80 Not reported
∗
84 5.52 0.39 5.72
Yes 984 6.40 699 6.59 2.59 5.47
Primary care provider <.0001 .0014
No 416 4.22 11.22 5.92 N/A
∗
Yes 505 1.03 12.31 3.88
Facilities ownershipx <.0001 <.0001
Physician or physician group. 522 4.54 16.11 6.13 N/A
∗
Medical/academic/community health
center, other hospitals.
270 15.40 3.64 16.20
Insurance company, health plan,
HMO, health care
corporation, other.
186 8.64 4.76 10.17
Practice regionjj <.0001 .0642 <.0001 .0004
Northeast 192 7.79 4.93 7.35 281 10.27 1.02 10.57
Midwest 198 4.91 3.17 4.73 138 4.98 0.61 4.81
South 360 6.67 10.79 8.40 273 6.46 1.08 5.14
West 252 6.37 6.18 8.11 91 3.80 0.28 2.54
Metropolitan statistical area (MSA) <.0001 .1681
MSA 944 6.70 23.23 7.63 N/A
∗
Non-MSA 58 3.29 1.83 5.33
Patient seen before <.0001 <.0001 .0051
Yes, established patient 705 5.52 18.10 6.47 18
∗
3.46 Not reported
∗
No, new patient 297 9.61 6.96 11.78 665 6.66
Episode of care .6971
Initial visits N/A 639 6.25 2.49 5.36
Follow-up visits 49 6.06 0.16 4.92
Data source: National Ambulatory Medical Care Survey & National Hospital Ambulatory Medical Care Survey.
Internal medicine, cardiovascular diseases, psychiatry, and neurology specialties were combined with other specialties not listed because estimates for those specialties did not meet NCHS standards of reliability.
∗
Frequency was less than 30 for “not reported” category which leads to unreliable estimates, thus it was excluded in final analyses; while N/A represents not available.
† Statistically significant at P< .01 at bivariate level.
‡ Pre-/postsurgery is excluded due to low unweighted frequency (n=11).
x NAMCS began reporting these combined categories in 2012.
jj Region of practice location (2009–11), location where majority of visit records were sampled (2012–14).
HIV = human immunodeficiency virus, NAMCS = National Ambulatory Medical Care Survey, NHAMCS = National Hospital Ambulatory Medical Care Survey.
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Table 3
Predictors of HIV testing among patients attending physician offices, pooled NAMCS data 2009 to 2014.
Physician office
Unweighted estimates Weighted estimates
Characteristic Odds ratio 99% CI P-value Odds ratio 99% CI P-value
Yr†
2009 Reference – – Reference – –
2010 1.37 0.97–1.94 .018 1.51 0.78–2.93 .1071
2011 1.54 1.09–2.18 .001 1.07 0.53–1.16 .806
2012 0.93 0.65–1.32 .589 1.01 0.53–1.92 .982
2013 1.28 0.91–1.81 .067 1.50 0.75–2.97 .130
2014 2.07 1.49–2.88 <.001 2.18 1.04–4.57 .007
∗
Patient-level characteristics
Age, yr†
13–19 1.29 0.85–1.96 .111 1.32 0.68–2.58 .284
20–29 5.39 4.02–7.21 <.001 7.20 4.37–11.85 <.001
∗
30–39 3.67 2.73–4.95 <.001 4.46 2.79–7.13 <.001
∗
40–49 2.10 1.52–2.90 <.001 2.20 1.35–3.58 <.001
∗
50–64 Reference – – Reference – –
Sex
Female Reference – – Reference – –
Male 1.34 1.11–1.62 <.001 1.34 0.91–0.93 .004
Race†
White Reference – – Reference – –
African American 2.80 2.25–3.50 <.001 2.97 2.05–4.31 <.001
∗
Other 1.21 0.83–1.77 .190 1.33 0.83–2.17 .124
Ethnicity†
Not Hispanic/Latino Reference – – Reference – –
Hispanic/Latino 1.77 1.39–2.25 <.001 1.80 1.17–2.78 <.001
∗
Primary source of payment†
Private Reference – – Reference – –
Medicare 0.82 0.48–1.40 .329 0.60 0.23–1.56 .169
Medicaid 1.14 0.89–1.47 .170 1.08 0.69–1.70 .643
Self-pay 0.76 0.51–1.14 .078 0.47 0.24–0.94 .005
∗
Others/unknown 1.21 0.83–1.77 .070 0.92 0.52–1.62 .705
Major reason for visit†,‡
Chronic problem Reference – – Reference – –
New problem (<3 mo) 1.28 0.98–1.69 .019 1.54 0.86–2.77 .056
Preventive care 4.41 3.45–5.63 <.001 5.29 3.25–8.61 <.001
∗
Arthritis† (does patient now have arthritis)
No Reference – – Reference
Yes 0.57 0.35–0.92 .002 0.53 0.22–1.26 .058
Diabetes† (does patient now have diabetes)
No Reference – – Reference
Yes 0.64 0.42–0.99 .009 0.68 0.38–1.23 .094
Obesity (does patient now have obesity)
No Reference – – Reference
Yes 1.03 0.75–1.41 .802 1.32 0.82–2.14 .133
System-level characteristics
Patient seen before†
Yes, established patient Reference – – Reference – –
No, new patient 1.93 1.55–2.41 <.001 1.78 1.23–2.58 <.001
∗
Primary care provider†
Visited primary care provider Reference – – Reference – –
Visited other providers 1.96 1.59–2.40 <.001 1.61 1.04–2.50 .004
∗
Ownership of the facilities†,x
Physician or physician group. Reference – – Reference – –
Medical/academic/community health center/other hospitals. 2.06 1.62–2.62 <.001 2.21 1.16–4.24 .002
∗
Insurance company, health plan, HMO,
health care corporation, other.
1.66 1.30–2.11 <.001 1.56 0.95–2.55 .021
∗
Practice regionjj
Midwest Reference – – Reference – –
Northeast 1.62 1.20–2.18 <.001 1.85 1.02–3.38 .008
∗
South 1.53 1.18–1.99 <.001 2.06 1.23–3.44 <.001
∗
West 1.43 1.08–1.89 <.001 1.94 1.07–3.51 .004
∗
Metropolitan statistical area (MSA)
MSA Reference – – Reference – –
Non-MSA 0.51 0.34–0.76 <.001 0.78 0.40–1.52 .346
Source: National Ambulatory Medical Care Survey (NAMCS).
CI = confidence interval, HIV = human immunodeficiency virus, NAMCS = National Ambulatory Medical Care Survey.
∗
Statistically significant at P< .01 level multivariate analyses.
†Statistically significant at P< .01 at bivariate level.
‡Pre-/postsurgery was excluded due to lower frequency (N=11).
xNAMCS began reporting these combined categories in 2012.
jjRegion of practice location (2009–11), location where majority of visit records were sampled (2012–14).
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4.1. Patient-level characteristics
Consistent with previous studies, African-Americans and His-
panics remainedmost likely to test forHIV inbothphysicianoffices
and ED.[20,21] African Americans and Hispanics have increased
risk of HIV infection, and account for most new HIV diagno-
ses.[24,25] However, HIV testing wasmost likely to occur in the ED
for bothAfrican-Americans andHispanics. This agreeswith recent
study findings showing minority Medicaid recipients and the
uninsured as most likely to receive HIV testing in the ED.[21] One
factor predictingwhereminority populations receiveHIV testing is
a lack of a usual source of care. Race, mistrust of the health system,
segregation in primary care based on socioeconomic status are
factors influencingminorities use of the ED for routine care and by
extension HIV testing.[26] In contrast to the literature, this study
found the highest likelihood for HIV testing by age occurring
among those aged 20 to 29 in physician offices. This contradicts
Table 4
Predictors of HIV testing in emergency departments, pooled NHAMCS data 2009 to 2014.
Emergency department
Unweighted estimates Weighted estimates
Characteristic Odds ratio 99% CI P Odds ratio 99% CI P
Yr
2009 Reference – – Reference – –
2010 1.78 1.26–2.53 <.001 2.79 1.13–6.88 .004
∗
2011 1.64 1.14–2.37 <.001 3.20 1.31–7.82 .001
∗
2012 1.95 1.36–2.79 .001 2.74 0.95–7.92 .014
2013 1.60 1.09–2.35 <.001 3.72 1.20–11.56 .003
∗
2014 2.01 1.39–2.90 .002 3.09 1.20–7.99 .002
∗
Patient-level characteristics
Age, yr
13–19 1.19 0.81–1.76 .238 0.95 0.47–1.92 .856
20–29 1.46 1.06–2.01 .002 1.22 0.76–1.95 .280
30–39 1.37 0.98–1.91 .015 1.26 0.77–1.95 .229
40–49 1.27 0.90–1.79 .072 1.12 0.69–1.80 .557
50–64 Reference – – Reference – –
Sex
Female Reference – – Reference – –
Male 0.98 0.79–1.18 .663 1.06 0.81–1.38 .601
Race†
White Reference – – Reference – –
African American 2.86 2.32–3.53 <.001 3.44 2.27–5.22 <.001
∗
Other 2.43 1.60–3.70 <.001 1.92 0.83–4.44 .045
Ethnicity†
Not Hispanic/Latino Reference – – Reference – –
Hispanic/Latino 1.98 1.55–2.53 <.001 2.24 1.51–3.31 <.001
∗
Primary source of payment†
Private Reference – – Reference – –
Medicare 1.00 0.60–1.65 1.00 0.71 0.34–1.44 .208
Medicaid 1.75 1.32–2.30 <.001 1.26 0.81–1.94 .176
Self-pay 1.27 0.91–1.78 .068 1.03 0.60–1.78 .895
Others/unknown 1.96 1.43–2.68 <.001 1.35 0.61–3.0 .328
Diabetes (does patient have diabetes)
No Reference – – Reference
Yes 0.88 0.58–1.33 .409 0.71 0.41–1.21 .098
System-level characteristics
Physician seen‡
Not seen Reference – – Reference – –
Seen 1.28 0.93–1.77 .047 1.17 0.64–2.12 .500
Episode of care
Follow-up visits Reference – – Reference – –
Initial visits 1.09 0.74–1.59 .580 1.07 0.61–1.85 .767
Practice region†,x
Midwest Reference – – Reference – –
Northeast 1.81 1.37–2.40 <.001 2.24 0.88–5.67 .026
South 1.00 0.74–1.34 .975 0.96 0.38–2.41 .909
West 0.68 0.47–0.99 .009 0.57 0.26–1.26 .067
Data source: National Hospital Ambulatory Medical Care Survey.
CI = confidence interval, HIV = human immunodeficiency virus, NAMCS = National Ambulatory Medical Care Survey.
∗
Statistically significant at P< .01 level multivariate analyses.
†Statistically significant at P< .01 at bivariate level.
‡Seen by attending physician or consultant in ED.
xRegion of practice location (2009–11), location where majority of visit records were sampled (2012–14).
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previous study findings of no difference in HIV testing by age.[5]
The finding that visits to a primary care provider had lower odds of
getting HIV tested is expected. Primary care providers often have
in-depth knowledge of their patients, which enables them to assess
risk and determine if a patient needs HIV testing. As a result,
providers may be less prone to provide/recommendHIV screening
during such visits. In contrast, a previous study that analyzed
NAMCS survey focusing onmen aged 15 to 25 years reported that
visits to the primary care physician had a higher likelihood forHIV
testing in physician offices.[3]
Findings from previous literature associated with the influence
of primary payment source onHIV testing are mixed. Some of the
studies support our finding of no significant effect on HIV testing
for most payment sources except for self-pay patients who had a
lesser likelihood of HIV testing.[5] Other studies reported the
opposite, with Medicaid recipients reported to test more often in
both physician offices and EDs.[21] Carter et al did not find any
variation in HIV testing among men aged 15 to 25 years in
physician office visits based on payment type.[27]
4.2. System-level characteristics
In general, patients visiting medical, academic, community health
centers, or other hospitals regulated by insurance company,
health plan, Health Maintenance Organizations (HMO) or
health corporation had higher odds for HIV testing. A prior study
established that patient-provider interaction plays a leading role
in subsequent decision making of the physician.[28] This study
found that established patients had significantly lower odds of
getting tested for HIV while visiting physician offices, but no
significant variations were reported for ED visits. Lower testing
rates for established patients are plausible because in most cases
there is ongoing physician-patient engagement and as well as an
established medical history. Another important systems-level
characteristic is the provider’s interaction with the health system.
A prior study demonstrated that provider decision-making is
largely affected by the type of facilities, region of the facilities, and
whether the facility is in metro or non-metro areas.[28] In this
study people from the South had significantly higher odds of
getting anHIV test during a physician office visit. HIV testing was
higher in the Northeast region for visits to the ED and in the
South for physician office visits. Findings related to the influence
of region on HIV testing are mixed.[5,21,29] A recent study
examining regional impact on HIV testing during patient visits
supports our finding.[21] Another study conducted on ED visits
did not find significant variation across geographic regions for
HIV testing.[5] However two 2018 studies report on the
prevalence of undiagnosed HIV in the ED, as well as the
difficulties in selecting patients for screening in the ED[30,31]
Encouragingly, the likelihood of being tested for HIV increased
significantly among visits to the ED as well as during preventative
care visits to physician offices. The finding that the likelihood for
HIV testing is higher for new patient visits in physician offices is
expected. New patient visits typically include the investigation of
existing chronic conditions with appropriate testing including
HIV testing. But contrary to the finding of no differences by type
of setting by Tai &Merchant (2014), we found HIV testing rates
were not uniformed between physician offices and ED. Plausible
explanations for the reason of HIV testing differs across both
health care settings were not assessed during this study. Reasons
provided by previous studies about failure to conduct routine
HIV testing in health settings among clinicians include a lack of
knowledge of the CDC’s testing guidelines; belief that patients are
not at risk for HIV and assuming HIV testing is the responsibility
of other health care professionals.[20]
In addition, lack of awareness and misconceptions regarding
HIV testing by physicians and the patients, barriers at facility and
legislative levels, costs associated with testing are major barriers
affecting the CDC’s recommendation.[30] Additional explanations
for these variations include the following. First, full adoption of the
2006CDCguidelines takes time and implementationmay differ by
health facility. There could also be facility and legislative level
barriers, along with lack of awareness, resistance, and mis-
conceptions regarding HIV testing by both physicians and
patients.[32] Second, in the absence of a clear mandate for
clinicians and health facilities to perform routineHIV screening, as
well as poor communication or dissemination of the CDC
guidelines, uptake in HIV testing rates may lag across health
settings. Third, the lack of strategic planning and financial support
to purchase and deploy portable point of care HIV testing
equipment could limit uptake of HIV testing in health settings.[7]
Fourth, physician behavior and reaction to the guidelines directly
influenceHIVtestingamongpatients, andphysiciansmaycontinue
to rely on clinical presentations rather than the guidelines to
recommend HIV testing. Fifth, the NAMCS and NHAMCS data
may not accurately capture all HIV testing.
4.3. Study limitations
The results of this study should be considered with some
limitations in mind. HIV testing rates do not reflect exact
incidence rates. Incidence rates cannot be estimated since the
same patients could make more than 1 visit. Information about
who was offered testing and reasons why HIV testing was not
performed was not collected. Patients not tested might have
declined testing because of prior screening from another visit.
Unrecognized sampling biases might hamper the national
representativeness of the population sample, while errors in
data collection might affect appropriate measure of HIV testing
rates.[5,15,20] For instance, nonresponse to participate in the
survey might have resulted in underestimation or overestimation
of HIV testing. Moreover, sexual behavior or intravenous drug
use data are absent, so estimation of HIV testing representing
these factors was not possible.
5. Conclusions
The overall rates of HIV testing increased over the study period;
however, increased HIV testing rates are not uniformed across
different facilities and subpopulations. System level factors may
play a significant role in improving HIV testing among minority
populations. While our study could not investigate provider
knowledge and practice, factors such as lack of time, funding
constraints as well as lack of staff could impact decision to test or
offer testing. The lower rates of HIV testing observed in the ED is
worrisome, particularly for populations without a usual source of
care. Tailored interventions for the ED may be necessary to
reduce missed opportunities for HIV testing. To develop such
interventions, future studies should examine factors such as
reason of visit, testing history, and the reasons for offering/taking
or not offering/taking HIV tests to understand both clinician and
patients’ behavior appropriately. Future research should also
examine which sub-populations (based on demographics and
transmission risks) are more likely to get or not get tested,
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regardless of the health settings. In addition, future studies should
also assess the knowledge, clarity and application of CDC testing
guidelines among providers. Monitoring the response of health
care settings, providers and patients to the CDC’s HIV testing
guidelines is important to achieve the goal of increasing HIV
testing in the United States, and a key component of ending the
epidemic. Therefore, careful and thoughtful approaches are
needed for identifying HIV infections during physician and ED
visits nationally.
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